Answers are grounded in this paper and cite their sources.
Soft tissue sarcomas are the sixth most common cancer in children and collectively account for about seven percent of all pediatric cancers. The development of increasingly intensive, multimodality treatment protocols for these tumors has led to a steady increase in cure rates for these neoplasms, especially for rhabdomyosarcoma, the most common pediatric soft tissue sarcoma. This article provides an overview of the basic biology, clinical management, and clinical research for pediatric soft tissue sarcomas.
No takes yet. Share an insight, caveat, or question.
Wexler et al. (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: